Active Ingredients Per 30Ml
Caffeine 65 mg
Choline Salicylate (NSAID)* 870 mg
*nonsteroidal anti-inflammatory drug
The following Structured Product Label (SPL) was submitted to the FDA by Topco Associates Llc for the product Topcare Pain Reliever Simple Relief (NDC 36800-518). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients per 30ml, purpose, uses, warnings, do not use, ask a doctor before use if, ask a doctor or pharmacist before use if, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Caffeine 65 mg
Choline Salicylate (NSAID)* 870 mg
*nonsteroidal anti-inflammatory drug
Pain Reliever Aid
Pain Reliever / Fever Reducer (NSAID)
Reye's syndrome
Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.
Allergy alert
Salicylates (NSAIDs) may cause a severe allergic reaction which may include:
Stomach bleeding warning
This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
ask a health professional before use. It is especially important not to use salicylates (NSAIDs) during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
In case of overdose, get medical help or contact a Poison Control Center right away.
citric acid anhydrous, glycerin, propylene glycol, purified water, sodium benzoate, sodium citrate, sodium saccharin, sorbitol
Call 1-888-423-0139
NDC 36800-518-34
Pain
Simple Relief
8 OZ FL (237mL)
* Please review the disclaimer below.